Interrupting treatment of patients on immune-suppressing medicine doubles antibody response to COVID-19 booster
Risk of miscarriage may increase during the summer
27 June 2022Parental depression screening beyond the postpartum period has the potential to identify families needing support
28 June 2022Interrupting treatment of patients on immune-suppressing medicine doubles antibody response to COVID-19 booster
A major clinical trial, led by experts at the University of Nottingham working in partnership with several universities and NHS hospitals, has found that interrupting the treatment of vulnerable people on long-term immune-suppressing medicines for two weeks after a COVID-19 booster vaccination doubles their antibody response to the booster.
